Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act ...

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Researchers have unveiled a way to flip genes back on without slicing into the genome, a shift that could make CRISPR far ...

If you are wondering whether CRISPR Therapeutics at about US$53.84 is still priced attractively or already baking in a lot of expectations, you are asking the right question. The stock has seen a ...

The study used large-scale CRISPR gene-editing technology to systematically determine which genes are required as embryonic ...

The gene therapy success with Baby KJ, along with a new FDA program, have companies more interested in treating rare disease.

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Victoria Gray spent 34 years battling the debilitating pain of sickle cell disease. Then she volunteered to be the world's first "prototype" for a CRISPR therapy, based on technology invented at UC ...

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $53.84, demonstrating a -4.54% change from the preceding ...